Association of high-sensitivity cardiac troponin T with all-cause and cardiovascular mortality in older adults with low lean mass: A 14.6-year longitudinal study.

[1]  A. Jaffe,et al.  High-Sensitivity Cardiac Troponin T Elevation in Hypertrophic Cardiomyopathy Is Associated With Ventricular Arrhythmias. , 2023, Mayo Clinic proceedings.

[2]  S. Larsson,et al.  Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. , 2023, Metabolism: clinical and experimental.

[3]  Shanshan Shi,et al.  Nutrition-related diseases and cardiovascular mortality in American society: national health and nutrition examination study, 1999–2006 , 2022, BMC Public Health.

[4]  G. Filippatos,et al.  Prognostic Implications of N-terminal Pro-B Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved. , 2022, JACC. Heart failure.

[5]  M. Emdin,et al.  High-sensitivity troponins for outcome prediction in the general population: a systematic review and meta-analysis. , 2022, European journal of internal medicine.

[6]  Nana He,et al.  Relationship Between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview , 2021, Frontiers in Cardiovascular Medicine.

[7]  C. Celis-Morales,et al.  Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis , 2021, Journal of cachexia, sarcopenia and muscle.

[8]  K. Stark,et al.  Distribution and specificity of high-sensitivity cardiac troponin T in older adults without acute cardiac conditions: cross-sectional results from the population-based AugUR study , 2021, BMJ Open.

[9]  M. Bilodeau,et al.  How do we define and measure sarcopenia? A meta-analysis of observational studies. , 2021, Age and Ageing.

[10]  M. N. Kim,et al.  Risk stratification using sarcopenia status among subjects with metabolic dysfunction‐associated fatty liver disease , 2021, Journal of cachexia, sarcopenia and muscle.

[11]  T. Karlsen,et al.  Exercise training and high‐sensitivity cardiac troponin T in patients with heart failure with reduced ejection fraction , 2021, ESC heart failure.

[12]  Xin Gao,et al.  Sarcopenia, sarcopenic overweight/obesity and risk of cardiovascular disease and cardiac arrhythmia: A cross-sectional study. , 2020, Clinical nutrition.

[13]  A. Tveit,et al.  Cardiac Troponin I and T Are Associated with Left Ventricular Function and Structure: Data from the Akershus Cardiac Examination 1950 Study. , 2020, Clinical chemistry.

[14]  E. Kang,et al.  Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk. , 2020, The American journal of gastroenterology.

[15]  G. Dagenais,et al.  Variability in High-Sensitivity Cardiac Troponin T Testing in Stable Patients With and Without Coronary Artery Disease. , 2019, The Canadian journal of cardiology.

[16]  C. Pinho,et al.  Sarcopenia and sarcopenic obesity as prognostic predictors in hospitalized elderly patients with acute myocardial infarction , 2019, Einstein.

[17]  Kristina Norman,et al.  Financial impact of sarcopenia or low muscle mass - A short review. , 2019, Clinical nutrition.

[18]  Y. Morino,et al.  Association between high-sensitivity cardiac troponin T and future cardiovascular incidence in a general Japanese population: results from the Tohoku medical megabank project , 2019, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[19]  A. Sayer,et al.  Sarcopenia , 2019, The Lancet.

[20]  M. Woodward,et al.  Cardiac Troponin T and Troponin I in the General Population , 2019, Circulation.

[21]  Tamas Fulop,et al.  Increased level of high-sensitivity cardiac Troponin T in a geriatric population is determined by comorbidities compared to age , 2019, International journal of cardiology. Heart & vasculature.

[22]  Wei Wu,et al.  Comparison of prognostic values of high-sensitivity cardiac troponin T and N-terminal prohormone brain natriuretic peptide to assess mortality in elderly inpatients , 2018, Clinical interventions in aging.

[23]  M. Woodward,et al.  Comparison between High-Sensitivity Cardiac Troponin T and Cardiac Troponin I in a Large General Population Cohort. , 2018, Clinical chemistry.

[24]  Kristian Thygesen,et al.  Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.

[25]  S. Kirkpatrick,et al.  Update of the Healthy Eating Index: HEI-2015. , 2018, Journal of the Academy of Nutrition and Dietetics.

[26]  G. Lip,et al.  2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.

[27]  A. Jaffe,et al.  Possible mechanisms behind cardiac troponin elevations , 2018, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[28]  S. Torii,et al.  Lean Soft Tissue Mass Measured Using Dual-Energy X-Ray Absorptiometry Is an Effective Index for Assessing Change in Leg Skeletal Muscle Mass Following Exercise Training. , 2018, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[29]  Wei Wu,et al.  Relationship between high-sensitivity cardiac troponin T and the prognosis of elderly inpatients with non-acute coronary syndromes , 2018, Clinical interventions in aging.

[30]  Johannes Schmid,et al.  Elevated Cardiac Troponin T in Patients With Skeletal Myopathies. , 2018, Journal of the American College of Cardiology.

[31]  D. Monneret,et al.  Determination of age- and sex-specific 99th percentiles for high-sensitive troponin T from patients: an analytical imprecision- and partitioning-based approach , 2017, Clinical chemistry and laboratory medicine.

[32]  N. Sattar,et al.  High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants , 2017, Journal of the American College of Cardiology.

[33]  M. Zeegers,et al.  Prognostic value of basal high-sensitive cardiac troponin levels on mortality in the general population , 2016, Medicine.

[34]  G. Schaaf,et al.  Elevated Plasma Cardiac Troponin T Levels Caused by Skeletal Muscle Damage in Pompe Disease , 2016, Circulation. Cardiovascular genetics.

[35]  H. Brunner-La Rocca,et al.  Clinical Interpretation of Elevated Concentrations of Cardiac Troponin T, but Not Troponin I, in Nursing Home Residents. , 2015, Journal of the American Medical Directors Association.

[36]  L. Geiss,et al.  Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. , 2015, JAMA.

[37]  K. Kamiya,et al.  Frailty may be a risk marker for adverse outcome in patients with congestive heart failure , 2015, ESC heart failure.

[38]  S. Seliger,et al.  Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction. , 2015, Clinical biochemistry.

[39]  Robert H Christenson,et al.  Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. , 2014, Journal of the American College of Cardiology.

[40]  K. Lewandrowski,et al.  Measurement of high-sensitivity troponin T in noncardiac medical intensive care unit patients. Correlation to mortality and length of stay. , 2014, American journal of clinical pathology.

[41]  Maren S Fragala,et al.  The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[42]  A. Go,et al.  Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC) , 2013, BMC Nephrology.

[43]  Lester R Curtin,et al.  National health and nutrition examination survey: analytic guidelines, 1999-2010. , 2013, Vital and health statistics. Series 2, Data evaluation and methods research.

[44]  A. Khera,et al.  Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. , 2010, JAMA.

[45]  T. Kawada,et al.  Association between high-sensitivity cardiac troponin T levels and the predicted cardiovascular risk in middle-aged men without overt cardiovascular disease. , 2010, American heart journal.

[46]  A. Jaffe,et al.  Analytical validation of a high-sensitivity cardiac troponin T assay. , 2010, Clinical chemistry.

[47]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[48]  L. Lind,et al.  Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. , 2008, European heart journal.

[49]  B. Kligler.  Ask the experts: Is there any real evidence that people who eat organic food are healthier? , 2007, Explore.

[50]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[51]  A. Torbicki,et al.  Cardiac troponin T monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism. , 2003, Chest.

[52]  S. Heymsfield,et al.  Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method. , 2002, The American journal of clinical nutrition.

[53]  S Greenland,et al.  Avoiding power loss associated with categorization and ordinal scores in dose-response and trend analysis. , 1995, Epidemiology.

[54]  P. Grambsch,et al.  Proportional hazards tests and diagnostics based on weighted residuals , 1994 .

[55]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[56]  G. Braemer.  International statistical classification of diseases and related health problems. Tenth revision. , 1988, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.